Professor
NOMIS Zentrum für Immunbiologie und mikrobielle Pathogenese
Becky und Ralph S. O'Connor-Stuhl
The immune system is a powerful, double-edged sword. On one hand, it is armed to fight a wide range of invading foreign pathogens. On the other hand, if left unchecked, it can also attack an organism’s own tissues and cause inflammation and autoimmune disorders such as allergies, asthma, rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. There are multiple safeguards built into our cells to prevent an autoimmune reaction, but these can go haywire. What’s more, some types of cancer can also evade or co-opt the immune system’s detection, allowing tumor cells to proliferate.
To learn how to strengthen or correct the immune system, Ye Zheng focuses on a specialized set of immune cells called regulatory T (Treg) cells. Tregs control the immune response, telling the more aggressive immune cells when to stop their frenzied attack. Abnormal Treg cell function has been linked to multiple autoimmune diseases and tumors. In particular, a key molecular component of these cells, a protein called Foxp3, is often responsible for deficient Tregs. Zheng is making advances in understanding the genes that control Foxp3—as well as genes that Foxp3 controls—to ultimately lead to ways to manage Treg cell function. Since manipulations of Treg cells can either weaken or strengthen the immune response, his findings can potentially open new avenues in the treatment of autoimmune diseases, improve organ transplant survival, and uncover new cancer targets.
Zheng hat Hunderte von Genen kartiert, die direkt mit dem Foxp3-Protein von Tregs zusammenhängen, um ein umfassenderes Bild davon zu erhalten, wie sich diese zellulären Friedensstifter entwickeln und funktionieren.
Zheng’s lab discovered that a particular genetic sequence in Foxp3 (called CNS2) is responsible for the stability of a Treg cell. If the team removed CNS2, Treg cells became unstable and often morphed into killer T cells—the type of cell Tregs are supposed to be controlling—resulting in autoimmune disease in animals.
His team identified a group of proteins directly regulated by Foxp3 that drives Treg cell function. These proteins can be targeted to boost Treg cell function for treatment of autoimmune diseases such as type 1 diabetes, allergy, and asthma.
BS, Biochemie und Molekularbiologie, Peking Universität, Peking, China
Promotion, Columbia University
Postdoktorand, University of Washington
Forschungsstipendiat des Memorial Sloan-Kettering Cancer Center
Postdoktoranden-Stipendium des Krebsforschungszentrums
